Calcium-independent phospholipase A2β-Akt signaling is involved in lipopolysaccharide-induced NADPH oxidase 1 expression and foam cell formation

Journal of Immunology

Volumn 183, Issue 11, 2009, Pages 7497-7504

  Lee, Sun Hye ^a   Park, Dae Weon ^a   Park, Sung Chul ^a   Park, Yun Ki ^a   Hong, Seong Yeon ^b   Kim, Jae Ryong ^a   Lee, Chu Hee ^a   Baek, Suk Hwan ^a  

^a Yeungnam University College of Medicine   (South Korea)

^b Catholic University of Daegu   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; APOCYNIN; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CALCIUM INDEPENDENT PHOSPHOLIPASE A2BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; OXIDOREDUCTASE; PHOSPHOLIPASE A2 GROUP IV; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FOAM CELL; GENE CONTROL; GENE EXPRESSION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; ATHEROSCLEROSIS; CALCIUM SIGNALING; CELL LINE; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ATHEROSCLEROSIS; BLOTTING, WESTERN; CALCIUM SIGNALING; CELL LINE; FLOW CYTOMETRY; FOAM CELLS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GROUP IV PHOSPHOLIPASES A2; LIPOPOLYSACCHARIDES; MICE; MICROSCOPY, CONFOCAL; NADH, NADPH OXIDOREDUCTASES; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 73349125092     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900503     Document Type: Article

References (48)

1. Glass, C. K., and J. L. Witztum. 2001. Atherosclerosis. the road ahead. Cell 104: 503-516.
2. Lee, J. G., E. J. Lim, D. W. Park, S. H. Lee, J. R. Kim, and S. H. Baek. 2008. A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation. Cell. Signal. 20: 2266-2275.
3. Funk, J. L., K. R. Feingold, A. H. Moser, and C. Grunfeld. 1993. Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis 98: 67-82.
4. Taniyama, Y., and K. K. Griendling. 2003. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42: 1075-1081. (Pubitemid 37549058)
5. Michelsen, K. S., M. H. Wong, P. K. Shah, W. Zhang, J. Yano, T. M. Doherty, S. Akira, T. B. Rajavashisth, and M. Arditi. 2004. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. USA 101: 10679-10684.
6. Ogier-Denis, E., S. B. Mkaddem, and A. Vandewalle. 2008. NOX enzymes and Toll-like receptor signaling. Semin. Immunopathol. 30: 291-300.
7. Suh, Y. A., R. S. Arnold, B. Lassegue, J. Shi, X. Xu, D. Sorescu, A. B. Chung, K. K. Griendling, and J. D. Lambeth. 1999. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401: 79-82.
8. Lassegue, B., D. Sorescu, K. Szocs, Q. Yin, M. Akers, Y. Zhang, S. L. Grant, J. D. Lambeth, and K. K. Griendling. 2001. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88: 888-894.
9. Katsuyama, M., C. Fan, and C. Yabe-Nishimura. 2002. NADPH oxidase is involved in prostaglandin F2α-induced hypertrophy of vascular smooth muscle cells: induction of NOX1 by PGF2α. J. Biol. Chem. 277: 13438-13442.
10. Fan, C. Y., M. Katsuyama, and C. Yabe-Nishimura. 2005. PKCdelta mediates up-regulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: possible involvement of PKCδ in vascular hypertrophy. Biochem. J. 390: 761-767.
11. Fan, C., M. Katsuyama, T. Nishinaka, and C. Yabe-Nishimura. 2005. Transactivation of the EGF receptor and a PI3 kinase-ATF-1 pathway is involved in the up-regulation of NOX1, a catalytic subunit of NADPH oxidase. FEBS Lett. 579: 1301-1305.
12. Katsuyama, M., M. Ozgur Cevik, N. Arakawa, T. Kakehi, T. Nishinaka, K. Iwata, M. Ibi, K. Matsuno, and C. Yabe-Nishimura. 2007. Myocyte enhancer factor 2B is involved in the inducible expression of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme. FEBS J. 274: 5128-5136. (Pubitemid 47481186)
13. Valente, A. J., Q. Zhou, Z. Lu, W. He, M. Qiang, W. Ma, G. Li, L. Wang, B. Banfi, K. Steger, K. H. Krause, R. A. Clark, and S. Li. 2008. Regulation of NOX1 expression by GATA, HNF-1α, and Cdx transcription factors. Free Radic. Biol. Med. 44: 430-443.
14. Arakawa, N., M. Katsuyama, K. Matsuno, N. Urao, Y. Tabuchi, M. Okigaki, H. Matsubara, and C. Yabe-Nishimura. 2006. Novel transcripts of Nox1 are regulated by alternative promoters and expressed under phenotypic modulation of vascular smooth muscle cells. Biochem. J. 398: 303-310. (Pubitemid 44338487)
15. Jenkins, C. M., X. Han, D. J. Mancuso, and R. W. Gross. 2002. Identification of calcium-independent phospholipase A2 (iPLA2)β, and not iPLA2γ, as the mediator of arginine vasopressin-induced arachidonic acid release in A-10 smooth muscle cells: enantioselective mechanism-based discrimination of mammalian iPLA2s. J. Biol. Chem. 277: 32807-32814.
16. Lambeth, J. D. 2004. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4: 181-189.
17. Lambeth, J. D. 2007. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic. Biol. Med. 43: 332-347.
18. Conway, J. P., and M. Kinter. 2006. Dual role of peroxiredoxin I in macrophage-derived foam cells. J. Biol. Chem. 281: 27991-28001.
19. Zandbergen, F., and J. Plutzky. 2007. PPARα in atherosclerosis and inflammation. Biochim. Biophys. Acta 1771: 972-982.
20. Liu, S. X., F. F. Hou, Z. J. Guo, R. Nagai, W. R. Zhang, Z. Q. Liu, Z. M. Zhou, M. Zhou, D. Xie, G. B. Wang, and X. Zhang. 2006. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler. Thromb. Vasc. Biol. 26: 1156-1162.
21. Sorescu, D., D. Weiss, B. Lassegue, R. E. Clempus, K. Szocs, G. P. Sorescu, L. Valppu, M. T. Quinn, J. D. Lambeth, J. D. Vega, W. R. Taylor, and K. K. Griendling. 2002. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105: 1429-1435. (Pubitemid 34263273)
22. Lee, J. G., S. H. Lee, D. W. Park, H. S. Yoon, B. R. Chin, J. H. Kim, J. R. Kim, and S. H. Baek. 2008. Toll-like receptor 9-stimulated monocyte chemoattractant protein-1 is mediated via JNK-cytosolic phospholipase A2-ROS signaling. Cell. Signal. 20: 105-111.
23. Brandes, R. P., and K. Schroder. 2008. Differential vascular functions of Nox family NADPH oxidases. Curr. Opin. Lipidol. 19: 513-518.
24. Kirk, E. A., M. C. Dinauer, H. Rosen, A. Chait, J. W. Heinecke, and R. C. LeBoeuf. 2000. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 20: 1529-1535.
25. -/-) mice. J. Clin. Invest. 108: 1513-1522.
26. Tobias, P., and L. K. Curtiss. 2005. Thematic review series: the immune system and atherogenesis - paying the price for pathogen protection: toll receptors in atherogenesis. J. Lipid. Res. 46: 404-411.
27. Michelsen, K. S., and M. Arditi. 2006. Toll-like receptor signaling and atherosclerosis. Curr. Opin. Hematol. 13: 163-168.
28. Kusumoto, K., T. Kawahara, Y. Kuwano, S. Teshima-Kondo, K. Morita, K. Kishi, and K. Rokutan. 2005. Ecabet sodium inhibits Helicobacter pylori lipopolysaccharide-induced activation of NADPH oxidase 1 or apoptosis of guinea pig gastric mucosal cells. Am. J. Physiol. 288: G300-G307.
29. Geiszt, M., K. Lekstrom, S. Brenner, S. M. Hewitt, R. Dana, H. L. Malech, and T. L. Leto. 2003. NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes. J. Immunol. 171: 299-306. (Pubitemid 36745301)
30. Kuwano, Y., T. Kawahara, H. Yamamoto, S. Teshima-Kondo, K. Tominaga, K. Masuda, K. Kishi, K. Morita, and K. Rokutan. 2006. Interferon γ activates transcription of NADPH oxidase 1 gene and up-regulates production of superoxide anion by human large intestinal epithelial cells. Am. J. Physiol. 290: C433-C443.
31. Wingler, K., S. Wunsch, R. Kreutz, L. Rothermund, M. Paul, and H. H. Schmidt. 2001. Up-regulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic. Biol. Med. 31: 1456-1464.
32. Katsuyama, M., C. Fan, N. Arakawa, T. Nishinaka, M. Miyagishi, K. Taira, and C. Yabe-Nishimura. 2005. Essential role of ATF-1 in induction of NOX1, a catalytic subunit of NADPH oxidase: involvement of mitochondrial respiratory chain. Biochem. J. 386: 255-261.
33. Teshima, S., H. Kutsumi, T. Kawahara, K. Kishi, and K. Rokutan. 2000. Regulation of growth and apoptosis of cultured guinea pig gastric mucosal cells by mitogenic oxidase 1. Am. J. Physiol. 279: G1169-G1176.
34. Rokutan, K., T. Kawahara, Y. Kuwano, K. Tominaga, A. Sekiyama, and S. Teshima-Kondo. 2006. NADPH oxidases in the gastrointestinal tract: a potential role of Nox1 in innate immune response and carcinogenesis. Antioxid. Redox Signal. 8: 1573-1582.
35. Bedard, K., and K. H. Krause. 2007. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87: 245-313.
36. Perner, A., L. Andresen, G. Pedersen, and J. Rask-Madsen. 2003. Superoxide production and expression of NAD(P)H oxidases by transformed and primary human colonic epithelial cells. Gut 52: 231-236.
37. Carnevale, K. A., and M. K. Cathcart. 2001. Calcium-independent phospholipase A2 is required for human monocyte chemotaxis to monocyte chemoattractant protein 1. J. Immunol. 167: 3414-3421.
38. Mishra, R. S., K. A. Carnevale, and M. K. Cathcart. 2008. iPLA2β: front and center in human monocyte chemotaxis to MCP-1. J. Exp. Med. 205: 347-359.
39. Balsinde, J., R. Perez, and M. A. Balboa. 2006. Calcium-independent phospholipase A2 and apoptosis. Biochim. Biophys. Acta 1761: 1344-1350.
40. Nikolic, D. M., M. C. Gong, J. Turk, and S. R. Post. 2007. Class A scavenger receptor-mediated macrophage adhesion requires coupling of calcium-independent phospholipase A2 and 12/15-lipoxygenase to Rac and Cdc42 activation. J. Biol. Chem. 282: 33405-33411.
41. Herbert, S. P., and J. H. Walker. 2006. Group VIA calcium-independent phospholipase A2 mediates endothelial cell S-phase progression. J. Biol. Chem. 281: 35709-35716.
42. Jenkins, C. M., M. J. Wolf, D. J. Mancuso, and R. W. Gross. 2001. Identification of the calmodulin-binding domain of recombinant calcium-independent phospholipase A2β: implications for structure and function. J. Biol. Chem. 276: 7129-7135.
43. Ishimoto, Y., K. Yamada, S. Yamamoto, T. Ono, M. Notoya, and K. Hanasaki. 2003. Group V and X secretory phospholipase A2s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions. Biochim. Biophys. Acta 1642: 129-138.
44. Sato, H., R. Kato, Y. Isogai, G. Saka, M. Ohtsuki, Y. Taketomi, K. Yamamoto, K. Tsutsumi, J. Yamada, S. Masuda, et al. 2008. Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. J. Biol. Chem. 283: 33483-33497.
45. Boyanovsky, B. B., P. Shridas, M. Simons, D. R. van der Westhuyzen, and N. R. Webb. 2008. Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified low density lipoprotein. J. Lipid Res. 50: 641-650.
46. 2 in vascular disease. Circ. Res. 89: 298-304.
47. Rosengren, B., H. Peilot, M. Umaerus, A. C. Jonsson-Rylander, L. Mattsson-Hulten, C. Hallberg, P. Cronet, M. Rodriguez-Lee, and E. Hurt-Camejo. 2006. Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet. Arterioscler. Thromb. Vasc. Biol. 26: 1579-1585.
48. Karabina, S. A., I. Brocheriou, G. Le Naour, M. Agrapart, H. Durand, M. Gelb, G. Lambeau, and E. Ninio. 2006. Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function. FASEB J. 20: 2547-2549.